Literature DB >> 15973438

Bacterial transfer of large functional genomic DNA into human cells.

A Laner1, S Goussard, A S Ramalho, T Schwarz, M D Amaral, P Courvalin, D Schindelhauer, C Grillot-Courvalin.   

Abstract

Efficient transfer of chromosome-based vectors into mammalian cells is difficult, mostly due to their large size. Using a genetically engineered invasive Escherichia coli vector, alpha satellite DNA cloned in P1-based artificial chromosome was stably delivered into the HT1080 cell line and efficiently generated human artificial chromosomes de novo. Similarly, a large genomic cystic fibrosis transmembrane conductance regulator (CFTR) construct of 160 kb containing a portion of the CFTR gene was stably propagated in the bacterial vector and transferred into HT1080 cells where it was transcribed, and correctly spliced, indicating transfer of an intact and functional locus of at least 80 kb. These results demonstrate that bacteria allow the cloning, propagation and transfer of large intact and functional genomic DNA fragments and their subsequent direct delivery into cells for functional analysis. Such an approach opens new perspectives for gene therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15973438     DOI: 10.1038/sj.gt.3302576

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  17 in total

Review 1.  Human artificial chromosomes for gene delivery and the development of animal models.

Authors:  Yasuhiro Kazuki; Mitsuo Oshimura
Journal:  Mol Ther       Date:  2011-07-12       Impact factor: 11.454

2.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

3.  Hybrid biosynthetic gene therapy vector development and dual engineering capacity.

Authors:  Charles H Jones; Anitha Ravikrishnan; Mingfu Chen; Ryan Reddinger; Mahmoud Kamal Ahmadi; Snehal Rane; Anders P Hakansson; Blaine A Pfeifer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

4.  Proliferation behavior of E. coli in a three-dimensional in vitro tumor model.

Authors:  Nelita Elliott; Tae Lee; Lingchong You; Fan Yuan
Journal:  Integr Biol (Camb)       Date:  2011-05-10       Impact factor: 2.192

5.  Characterization of a large human transgene following invasin-mediated delivery in a bacterial artificial chromosome.

Authors:  Austin E Gillen; Catherine A Lucas; Pei Ling Haussecker; Steven T Kosak; Ann Harris
Journal:  Chromosoma       Date:  2013-06-09       Impact factor: 4.316

6.  Assessing the functional characteristics of synonymous and nonsynonymous mutation candidates by use of large DNA constructs.

Authors:  A M Eeds; D Mortlock; R Wade-Martins; M L Summar
Journal:  Am J Hum Genet       Date:  2007-03-08       Impact factor: 11.025

7.  Polymyxin B treatment improves bactofection efficacy and reduces cytotoxicity.

Authors:  Charles H Jones; Snehal Rane; Emily Patt; Anitha Ravikrishnan; Chih-Kuang Chen; Chong Cheng; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-18       Impact factor: 4.939

8.  Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.

Authors:  Sara Pérez-Luz; Javier Díaz-Nido
Journal:  J Biomed Biotechnol       Date:  2010-08-24

9.  Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli.

Authors:  M D B Larsen; U Griesenbach; S Goussard; D C Gruenert; D M Geddes; R K Scheule; S H Cheng; P Courvalin; C Grillot-Courvalin; E W F W Alton
Journal:  Gene Ther       Date:  2008-01-24       Impact factor: 5.250

10.  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Authors:  Jerome S Harms; Marina A Durward; Diogo M Magnani; Gary A Splitter
Journal:  J Immune Based Ther Vaccines       Date:  2009-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.